Investors

News Releases

Date Title  
Toggle Summary RETRANSMISSION: Tribute Schedules Special Shareholder Meeting for February 1, 2016
MILTON, ONTARIO -- (Marketwired) -- 12/29/15 -- Tribute Pharmaceuticals Canada    Inc. (TSX VENTURE:TRX) (OTCQX:TBUFF) ("Tribute" or the "Company"), a specialty    pharmaceutical company with a primary focus on the acquisition, licensing,    development and promotion
Toggle Summary POZEN Announces Effectiveness Of Aralez Registration Statement On Form S-4 And Provides Update On Key Milestones For 2016
- POZEN schedules stockholder meeting for February 2 , 2016-  -Plan to re-file YOSPRALA™ New Drug Application early in the second quarter; Approval and launch targeted in fourth quarter-  CHAPEL HILL, N.C. , Dec. 28, 2015 /PRNewswire/ --   POZEN Inc.
Toggle Summary Tribute Schedules Special Shareholder Meeting for February 1, 2016
    MILTON, ONTARIO -- (Marketwired) -- 12/28/15 -- Tribute Pharmaceuticals Canada    Inc. (TSX VENTURE:TRX) (OTCQX:TBUFF) ("Tribute" or the "Company"), a specialty    pharmaceutical company with a primary focus on the acquisition, licensing,    development and promotion of healthcare products in
Toggle Summary POZEN And Tribute Announce Plan To Proceed With Merger To Form Aralez Pharmaceuticals
- US$350 Million Capital Commitment from Deerfield-Led Syndicate- -Canada Domicile Provides Similar Competitive Structure and Benefits to Ireland - -Previously Scheduled Shareholder Meetings of POZEN and Tribute to be Rescheduled- CHAPEL HILL, N.C. and MILTON, Ontario , Dec.
Toggle Summary POZEN and Tribute Announce Plan to Proceed With Merger to Form Aralez Pharmaceuticals
     -Canada Domicile Provides Similar Competitive    Structure and Benefits to Ireland-     -Previously Scheduled Shareholder Meetings of    POZEN and Tribute to be Rescheduled-     CHAPEL HILL, NORTH CAROLINA and MILTON, ONTARIO -- (Marketwired) -- 12/07/15 --    POZEN Inc.
Toggle Summary POZEN And Tribute Provide Update On Pending Combination Transactions
-POZEN and Tribute Evaluating Canadian Domicile for Aralez Pharmaceuticals- CHAPEL HILL, NORTH CAROLINA and MILTON, ONTARIO -- ( Marketwired ) -- 11/23/15 -- POZEN Inc. ("POZEN") (NASDAQ:POZN) and Tribute Pharmaceuticals Canada Inc. ("Tribute") (TSX VENTURE:TRX) (OTCQX:TBUFF) today provided an
Toggle Summary Tribute Announces Third Quarter 2015 Results
    Revenue Up 133%, EBITDA Up 281% Over    Comparative Period     MILTON, ONTARIO -- (Marketwired) -- 11/09/15 -- Tribute Pharmaceuticals Canada    Inc. (TSX VENTURE:TRX)(OTCQX:TBUFF) ("Tribute" or the "Company"), a diversified    healthcare company with a primary focus on the acquisition,
Toggle Summary POZEN Reports Third Quarter 2015 Results
Strategic Merger with Tribute Pharmaceuticals Still on Track to Close in December 2015 Commercial Launch Preparation Efforts for YOSPRALA TM Well Underway CHAPEL HILL, N.C. --(BUSINESS WIRE)--Nov. 9, 2015-- POZEN Inc. (NASDAQ: POZN) , today announced results for the third quarter ended September
Toggle Summary POZEN and Tribute Announce Effectiveness of Registration Statement on Form S-4
    POZEN Schedules Stockholder Meeting for December 10, 2015     Tribute Schedules Shareholder Meeting for December 9, 2015     CHAPEL HILL, N.C. & MILTON, Ontario--November 6, 2015--POZEN Inc. ("POZEN")    (POZN) and Tribute Pharmaceuticals Canada Inc.
Toggle Summary POZEN Inc. to Announce Third Quarter 2015 Results on November 9, 2015
Company to host call at 11:00 a.m. ET CHAPEL HILL, N.C. --(BUSINESS WIRE)--Oct. 26, 2015-- POZEN Inc. (NASDAQ: POZN) today announced that the Company plans to release results for the third quarter 2015 on Monday, November 9, 2015 , before the opening of the U.S. markets.

Copyright West LLC. Minimum 15 minutes delayed.